Plain-English translation of NCT07755761 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new surgical approach called Innovative Tube Trabeculectomy for people with advanced glaucoma that hasn't responded to eye drops or previous surgery. The new technique includes special preparation before surgery, medicines injected under the eye, and a modified surgical procedure designed to prevent scarring and keep the surgery working longer. Researchers will compare this new approach to the standard glaucoma surgery that doctors have used for many years.
Standard glaucoma surgery can fail over time because scar tissue forms and blocks the new drainage channel created by surgery. This trial exists to see whether the new treatment technique can reduce scarring and keep eye pressure controlled better than the standard approach, helping people avoid vision loss from advanced glaucoma.
You likely qualify if…
You likely don't qualify if…
If you are randomized to the new technique group, you will begin a 3-week preparation period that includes stopping certain eye drops and starting a specific steroid eye drop. You will then receive injections under the eye one week before surgery. On surgery day, you will receive the Innovative Tube Trabeculectomy procedure. If you are randomized to the standard surgery group, you will receive the conventional trabeculectomy. Both groups will be followed for at least 12 months with regular eye exams to measure eye pressure, vision, visual field, and any complications, and to assess your quality of life.
AI-generated summary from trial data · Aug 10, 2026 · Not medical advice
Egypt